* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Dallah Healthcare Co's PEG Ratio or its related term are showing as below:
SAU:4004'
s PEG Ratio Range Over the Past 10 Years
Min: 1.04 Med: 2.59 Max: 139
Current: 1.8
During the past 13 years, Dallah Healthcare Co's highest PEG Ratio was 139.00. The lowest was 1.04. And the median was 2.59.
SAU:4004's PEG Ratio is ranked worse than 58.04% of 224
companies
in the Healthcare Providers & Services industry
Industry Median: 1.58
vs SAU:4004: 1.80
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Dallah Healthcare Co PEG Ratio Historical Data
The historical data trend for Dallah Healthcare Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dallah Healthcare Co's PEG Ratio
For the Medical Care Facilities subindustry, Dallah Healthcare Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co's PEG Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's PEG Ratio falls into.
Dallah Healthcare Co PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Dallah Healthcare Co (SAU:4004) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Dallah Healthcare Co PEG Ratio Related Terms
Thank you for viewing the detailed overview of Dallah Healthcare Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Dallah Healthcare Co (SAU:4004) Business Description
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Service/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SAU:4004 has been successfully added to your 